Thyroid Nodules and Thyroid Cancer: What Approaches to Diagnosis and Treatment are Recommended by American Thyroid Association in 2015
Journal Title: Міжнародний ендокринологічний журнал - Year 2016, Vol 2, Issue 74
Abstract
The critical review of the latest guidelines of world most valuable task force team of American Thyroid Association considers main of more than 100 recommendations on the diagnosis, treatment and long-term follow-up of patients with thyroid nodules and differentiated thyroid cancer. The possibility of using clinical guidelines in terms of the national health system has been estimated. Prospects of using genetic researches in differential diagnosis of thyroid tumors were considered. There has been stressed the importance of new predictive approach — dynamic risk assessment based on response to initial treatment, as well as reasonable and individualized attitude to radioiodine and the use of suppressive therapy with thyroid hormones in patients with differentiated carcinoma.
Authors and Affiliations
S. М. Cherenko
Dynamics of Endothelial Function Impairment in Patients with Initial Poor Compensation of Type 2 Diabetes Mellitus in Correction of Hypertension with Angiotensin II Receptor Antagonists during a year
The purpose of this study is to determine the dynamics of endothelial dysfunction intensity in patients with poor compensation of type 2 diabetes mellitus and hypertension treating with angiotensin II receptor antagonist...
Male hypogonadism (part 2)
The second part of the review shows the current approaches to the methods of diagnosis and treatment of various forms of hypogonadism in men.
Integrated Treatment of Diabetic Polyneuropathy
No abstract
Features of Thyroid Functional State in Patients with Type 2 Diabetes Mellitus and Obesity
We have observed 55 patients with diabetes mellitus (DM) type 2 and obesity without signs of thyroid function abnormality, as well as 60 patients with DM type 2 and obesity combined with overt or subclinical hypothyroidi...
Efficiency and Safety of Metformine and Pioglitazone in Patients with Coronary Heart Disease and Diabetes Mellitus Type 2
A combination of metformin (MF) (2 g daily) and pioglitazone (PG) (30 mg daily) in 57 patients with coronary heart disease (CHD) and diabetes mellitus type 2 (DM 2) reduces the indicators of low grade chronic inflammatio...